Basics |
180 Life Sciences Corp.
|
IPO Date: |
June 26, 2017 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$6.21M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.16 | 5.39%
|
Avg Daily Range (30 D): |
$0.06 | 5.64%
|
Avg Daily Range (90 D): |
$0.05 | 4.33%
|
Institutional Daily Volume |
Avg Daily Volume: |
.82M |
Avg Daily Volume (30 D): |
.12M |
Avg Daily Volume (90 D): |
.09M |
Trade Size |
Avg Trade Size (Sh.): |
208 |
Avg Trade Size (Sh.) (30 D): |
284 |
Avg Trade Size (Sh.) (90 D): |
275 |
Institutional Trades |
Total Inst.Trades: |
22 |
Avg Inst. Trade: |
$.86M |
Avg Inst. Trade (30 D): |
$.64M |
Avg Inst. Trade (90 D): |
$.64M |
Avg Inst. Trade Volume: |
M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$.82M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
.39K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-.67
|
$-13.25
|
$-15.49
|
Diluted EPS
|
$-.67
|
$-13.25
|
$-15.49
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -2.37M
|
$ -4.27M
|
$ -6.17M
|
Operating Income / Loss
|
$ -2.37M
|
$ -1.41M
|
$ -6.32M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ M
|
$ -.3M
|
$ -.05M
|
PE Ratio
|
|
|
|
Splits |
Feb 28, 2024:
1:19
|
Dec 19, 2022:
1:20
|
|